Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hepatic encephalopathy (HE) is a severe complication of TIPS treatment in patients with cirrhosis and variceal bleeding. Lactulose, is considered the first-line therapeutic agent for treating hepatic encephalopathy. Based on route of administration, Hepatic Encephalopathy Drugs include oral (tablets & solutions) and injections.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Hepatic Encephalopathy Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Hepatic Encephalopathy Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Hepatic Encephalopathy Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Norgine
Ferring Pharmaceuticals
ASKA Pharmaceutical
Cosmo Pharmaceuticals
Bausch Health
Mallinckrodt
Kannalife Sciences
Kaleido Biosciences
Umecrine Cognition
Lupin
By Type:
Antibiotics
Laxatives
L-ornithine L-aspartate
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hepatic Encephalopathy Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Antibiotics from 2016 to 2027
-
1.3.2 China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Laxatives from 2016 to 2027
-
1.3.3 China Hepatic Encephalopathy Drugs Market Size and Growth Rate of L-ornithine L-aspartate from 2016 to 2027
-
1.3.4 China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Hepatic Encephalopathy Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hepatic Encephalopathy Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Antibiotics
-
3.4.2 Market Size and Growth Rate of Laxatives
-
3.4.3 Market Size and Growth Rate of L-ornithine L-aspartate
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Hepatic Encephalopathy Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hepatic Encephalopathy Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Hepatic Encephalopathy Drugs in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Hepatic Encephalopathy Drugs in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Hepatic Encephalopathy Drugs in Online Pharmacies
5 Market Analysis by Regions
-
5.1 China Hepatic Encephalopathy Drugs Production Analysis by Regions
-
5.2 China Hepatic Encephalopathy Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Hepatic Encephalopathy Drugs Landscape Analysis
-
6.1 North China Hepatic Encephalopathy Drugs Landscape Analysis by Major Types
-
6.2 North China Hepatic Encephalopathy Drugs Landscape Analysis by Major End-Users
7 Central China Hepatic Encephalopathy Drugs Landscape Analysis
-
7.1 Central China Hepatic Encephalopathy Drugs Landscape Analysis by Major Types
-
7.2 Central China Hepatic Encephalopathy Drugs Landscape Analysis by Major End-Users
8 South China Hepatic Encephalopathy Drugs Landscape Analysis
-
8.1 South China Hepatic Encephalopathy Drugs Landscape Analysis by Major Types
-
8.2 South China Hepatic Encephalopathy Drugs Landscape Analysis by Major End-Users
9 East China Hepatic Encephalopathy Drugs Landscape Analysis
-
9.1 East China Hepatic Encephalopathy Drugs Landscape Analysis by Major Types
-
9.2 East China Hepatic Encephalopathy Drugs Landscape Analysis by Major End-Users
10 Northeast China Hepatic Encephalopathy Drugs Landscape Analysis
-
10.1 Northeast China Hepatic Encephalopathy Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Hepatic Encephalopathy Drugs Landscape Analysis by Major End-Users
11 Southwest China Hepatic Encephalopathy Drugs Landscape Analysis
-
11.1 Southwest China Hepatic Encephalopathy Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Hepatic Encephalopathy Drugs Landscape Analysis by Major End-Users
12 Northwest China Hepatic Encephalopathy Drugs Landscape Analysis
-
12.1 Northwest China Hepatic Encephalopathy Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Hepatic Encephalopathy Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Norgine
-
13.1.1 Norgine Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Ferring Pharmaceuticals
-
13.2.1 Ferring Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 ASKA Pharmaceutical
-
13.3.1 ASKA Pharmaceutical Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Cosmo Pharmaceuticals
-
13.4.1 Cosmo Pharmaceuticals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Bausch Health
-
13.5.1 Bausch Health Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Mallinckrodt
-
13.6.1 Mallinckrodt Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Kannalife Sciences
-
13.7.1 Kannalife Sciences Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Kaleido Biosciences
-
13.8.1 Kaleido Biosciences Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Umecrine Cognition
-
13.9.1 Umecrine Cognition Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Lupin
-
13.10.1 Lupin Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Antibiotics from 2016 to 2027
-
Figure China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Laxatives from 2016 to 2027
-
Figure China Hepatic Encephalopathy Drugs Market Size and Growth Rate of L-ornithine L-aspartate from 2016 to 2027
-
Figure China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Hepatic Encephalopathy Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Hepatic Encephalopathy Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Hepatic Encephalopathy Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Hepatic Encephalopathy Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hepatic Encephalopathy Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Hepatic Encephalopathy Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Antibiotics
-
Figure Market Size and Growth Rate of Laxatives
-
Figure Market Size and Growth Rate of L-ornithine L-aspartate
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Hepatic Encephalopathy Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Hepatic Encephalopathy Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Online Pharmacies
-
Table China Hepatic Encephalopathy Drugs Production by Regions
-
Table China Hepatic Encephalopathy Drugs Production Share by Regions
-
Figure China Hepatic Encephalopathy Drugs Production Share by Regions in 2016
-
Figure China Hepatic Encephalopathy Drugs Production Share by Regions in 2021
-
Figure China Hepatic Encephalopathy Drugs Production Share by Regions in 2027
-
Table China Hepatic Encephalopathy Drugs Consumption by Regions
-
Table China Hepatic Encephalopathy Drugs Consumption Share by Regions
-
Figure China Hepatic Encephalopathy Drugs Consumption Share by Regions in 2016
-
Figure China Hepatic Encephalopathy Drugs Consumption Share by Regions in 2021
-
Figure China Hepatic Encephalopathy Drugs Consumption Share by Regions in 2027
-
Table North China Hepatic Encephalopathy Drugs Consumption by Types from 2016 to 2027
-
Table North China Hepatic Encephalopathy Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Hepatic Encephalopathy Drugs Consumption Share by Types in 2016
-
Figure North China Hepatic Encephalopathy Drugs Consumption Share by Types in 2021
-
Figure North China Hepatic Encephalopathy Drugs Consumption Share by Types in 2027
-
Table North China Hepatic Encephalopathy Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Hepatic Encephalopathy Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2016
-
Figure North China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2021
-
Figure North China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2027
-
Table Central China Hepatic Encephalopathy Drugs Consumption by Types from 2016 to 2027
-
Table Central China Hepatic Encephalopathy Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Hepatic Encephalopathy Drugs Consumption Share by Types in 2016
-
Figure Central China Hepatic Encephalopathy Drugs Consumption Share by Types in 2021
-
Figure Central China Hepatic Encephalopathy Drugs Consumption Share by Types in 2027
-
Table Central China Hepatic Encephalopathy Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Hepatic Encephalopathy Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2016
-
Figure Central China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2021
-
Figure Central China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2027
-
Table South China Hepatic Encephalopathy Drugs Consumption by Types from 2016 to 2027
-
Table South China Hepatic Encephalopathy Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Hepatic Encephalopathy Drugs Consumption Share by Types in 2016
-
Figure South China Hepatic Encephalopathy Drugs Consumption Share by Types in 2021
-
Figure South China Hepatic Encephalopathy Drugs Consumption Share by Types in 2027
-
Table South China Hepatic Encephalopathy Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Hepatic Encephalopathy Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2016
-
Figure South China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2021
-
Figure South China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2027
-
Table East China Hepatic Encephalopathy Drugs Consumption by Types from 2016 to 2027
-
Table East China Hepatic Encephalopathy Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Hepatic Encephalopathy Drugs Consumption Share by Types in 2016
-
Figure East China Hepatic Encephalopathy Drugs Consumption Share by Types in 2021
-
Figure East China Hepatic Encephalopathy Drugs Consumption Share by Types in 2027
-
Table East China Hepatic Encephalopathy Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Hepatic Encephalopathy Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2016
-
Figure East China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2021
-
Figure East China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Hepatic Encephalopathy Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Hepatic Encephalopathy Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Hepatic Encephalopathy Drugs Consumption Share by Types in 2016
-
Figure Northeast China Hepatic Encephalopathy Drugs Consumption Share by Types in 2021
-
Figure Northeast China Hepatic Encephalopathy Drugs Consumption Share by Types in 2027
-
Table Northeast China Hepatic Encephalopathy Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Hepatic Encephalopathy Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Hepatic Encephalopathy Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Hepatic Encephalopathy Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Hepatic Encephalopathy Drugs Consumption Share by Types in 2016
-
Figure Southwest China Hepatic Encephalopathy Drugs Consumption Share by Types in 2021
-
Figure Southwest China Hepatic Encephalopathy Drugs Consumption Share by Types in 2027
-
Table Southwest China Hepatic Encephalopathy Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Hepatic Encephalopathy Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Hepatic Encephalopathy Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Hepatic Encephalopathy Drugs Consumption Share by Types in 2016
-
Figure Northwest China Hepatic Encephalopathy Drugs Consumption Share by Types in 2021
-
Figure Northwest China Hepatic Encephalopathy Drugs Consumption Share by Types in 2027
-
Table Northwest China Hepatic Encephalopathy Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Hepatic Encephalopathy Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Norgine
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Norgine
-
Figure Sales and Growth Rate Analysis of Norgine
-
Figure Revenue and Market Share Analysis of Norgine
-
Table Product and Service Introduction of Norgine
-
Table Company Profile and Development Status of Ferring Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Ferring Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Ferring Pharmaceuticals
-
Table Product and Service Introduction of Ferring Pharmaceuticals
-
Table Company Profile and Development Status of ASKA Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ASKA Pharmaceutical
-
Figure Sales and Growth Rate Analysis of ASKA Pharmaceutical
-
Figure Revenue and Market Share Analysis of ASKA Pharmaceutical
-
Table Product and Service Introduction of ASKA Pharmaceutical
-
Table Company Profile and Development Status of Cosmo Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals
-
Table Product and Service Introduction of Cosmo Pharmaceuticals
-
Table Company Profile and Development Status of Bausch Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bausch Health
-
Figure Sales and Growth Rate Analysis of Bausch Health
-
Figure Revenue and Market Share Analysis of Bausch Health
-
Table Product and Service Introduction of Bausch Health
-
Table Company Profile and Development Status of Mallinckrodt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt
-
Figure Sales and Growth Rate Analysis of Mallinckrodt
-
Figure Revenue and Market Share Analysis of Mallinckrodt
-
Table Product and Service Introduction of Mallinckrodt
-
Table Company Profile and Development Status of Kannalife Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kannalife Sciences
-
Figure Sales and Growth Rate Analysis of Kannalife Sciences
-
Figure Revenue and Market Share Analysis of Kannalife Sciences
-
Table Product and Service Introduction of Kannalife Sciences
-
Table Company Profile and Development Status of Kaleido Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kaleido Biosciences
-
Figure Sales and Growth Rate Analysis of Kaleido Biosciences
-
Figure Revenue and Market Share Analysis of Kaleido Biosciences
-
Table Product and Service Introduction of Kaleido Biosciences
-
Table Company Profile and Development Status of Umecrine Cognition
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Umecrine Cognition
-
Figure Sales and Growth Rate Analysis of Umecrine Cognition
-
Figure Revenue and Market Share Analysis of Umecrine Cognition
-
Table Product and Service Introduction of Umecrine Cognition
-
Table Company Profile and Development Status of Lupin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin
-
Figure Sales and Growth Rate Analysis of Lupin
-
Figure Revenue and Market Share Analysis of Lupin
-
Table Product and Service Introduction of Lupin
-
